vivo-TIL Therapeutics, Inc — Form D
vivo-TIL Therapeutics, Inc of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-04. The offering totals $940K, of which $940K was reported sold. Industry: Other Technology.
Offering
- Filed: 2018-01-04
- Form: D
- Accession: 0001727113-18-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $940K
- Amount sold: $940K
- Minimum investment: $5
- Investors: 7
- Date of first sale: 2017-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-302403
Issuer
- Name: vivo-TIL Therapeutics, Inc
- CIK: 0001727113
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2017
- Address: 454 N 34TH ST, SEATTLE, WA, 98103
- Phone: 206-225-7477
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Whitney O Leibow | Director | Seattle, WA |
| Laurie O Beitz | Executive Officer | Seattle, WA |
Other filings by this issuer (1)
More